全球幹細胞最新技術市場 是由出版商Markets and Markets在2009年11月所出版的。
這份英文市場調查報告書包含229 pages 價格從美金4650起跳。
Abstract
Report Description
The stem cell market is growing rapidly due to increasing regulatory approval
and public acceptance bodies. The benefits of stem cell therapy are attracting
an increasing number of patients. The product submarket for human and embryo
stem cells are expected to drive the growth of the overall market. In
addition, intensive R&D efforts and the increasing investments into research
on stem cells therapy are soon expected to improve the efficacy of stem cell
treatment. However, the high cost of the therapy may affect market growth. The
global stem cell market is estimated to be $88.3 billion by 2014, growing at a
CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the
global stem cell market; and forms an especially lucrative market for areas
such as bone marrow transplantation through stem cells. This research report
will help stakeholders gain a better understanding of product pricing and
regulatory framework governing the dynamics of the stem cell market. The key
players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell
Technologies, Genzyme Corp., Cytori, and Geron.
Market Estimates and Forecasts
The report categorizes the global stem cell market as follows:
- Stem Cell Products (adult stem cell, human embryonic stem cell, and
other stem cell types)
- Stem Cell Services (stem cell banking, stem cell acquisition and
testing, drug discovery and target identification, isolation/characterization
services, and molecular biology )
- Stem Cell Technologies (stem cell acquisition, stem cell
production, cryopreservation, and expansion and subculture)
- Stem Cell Applications (regenerative medicine - neurological
disorders, orthopedics, cancer, hematological disorders, myocardial infarction
and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence,
and drug development)
Each section will provide market data, market drivers, trends and
opportunities, top-selling products, key players, and competitive outlook.
This report will also provide market tables for various geographic regions
covering the sub-segments and micro-markets. In addition, the report also
provides more than 35 company profiles for each of its sub-segments.
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not
many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find
specific market intelligence that they are looking for. Our customization will
ensure that you necessarily get the market intelligence you are looking for
and we get a loyal customer.
- We conduct detailed market positioning, product positioning and
competitive positioning. Entry strategies, gaps and opportunities are
identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and
Electronics, Energy and Power Supplies, Food and Beverages, Chemicals,
Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze
retailers and super-retailers, technology providers, and research and
development (R&D) companies.
Key questions answered
- Which are the high-growth segments/cash cows and how is the market
segmented in terms of applications, products, services, ingredients,
technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and
which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the
segments; what are the key selling products; what are their strategic
directives, operational strengths and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and
market research firms, globally, adding their expertise and domain
understanding. We get the facts from over 22,000 news and information sources,
a huge database of key industry participants and draw on our relationships
with more than 900 market research companies across the world. We, at
MarketsandMarkets, are inspired to help our clients grow by providing
qualitative business insights with our huge market intelligence repository.
Table of Contents
Executive summary
- MARKET OVERVIEW
- Stem cell market dynamics
- Stem cells product market
- Stem cells technology market
- Stem cells services market
- Stem cells applications market
- Geographic analysis
- Competitive landscape
1. INTRODUCTION
- 1.1. KEY TAKE-AWAYS
- 1.2. REPORT DESCRIPTION
- 1.3. Research METHODOLOGY
- 1.4. STAKEHOLDERS
2. Summary
3. market overview
- 3.1. Defining the stem cell market
- 3.2. Factors influencing the stem cells market
- 3.3. Stem cell market inhibitors
- 3.4. Regenerative medicine dominates stem cell applications
- 3.5. FACTORS INFLUENCING THE STEM CELLS MARKET
- 3.5.1. U.S. lifts ban on funding
- 3.5.2. Guidelines for responsible stem cells research
- 3.5.3. European national policies and legal issues
- 3.5.4. E.U. funding for stem cells research
- 3.5.5. Asia Pacific
- 3.6. Stem cell patent analysis
4. Stem cell market dynamics
- 4.1. Drivers
- 4.1.1. Potential of stem cells in regenerative medicine
- 4.1.2. Key to anti-ageing and prolonging life
- 4.1.3. Increasing R&D INVESTMENTS in adult stem cell research
- 4.1.4. EASE of administration
- 4.1.5. Reduced risk of tissue rejection in transplants
- 4.1.6. Federal funding for stem cell research
- 4.2. Restraints
- 4.2.1. safety issues
- 4.2.2. Ethical issueS
- 4.2.3. Insurance issues
- 4.3. Opportunities
- 4.3.1. technological innovations
- 4.3.2. Emerging application as a drug discovery tool
- 4.3.3. other promising applications
5. Global stem cells product market
- 5.1. potency-based Stem cell classification
- 5.2. Adult stem cells
- 5.2.1. Drivers
- 5.2.1.1. Applications in cancer and chronic disease treatment
- 5.2.1.2. Availability of adequate safety & efficacy evidence
- 5.2.1.3. Technology innovations
- 5.2.1.4. Lower costs & no ethical issues
- 5.2.2. Restraints & Opportunities
- 5.2.2.1. Lower therapeutic potential
- 5.2.2.2. Need for minimising intervention
- 5.2.3. Hematopoietic Stem Cells
- 5.2.3.1. Drivers & Restraints
- 5.2.3.1.1. Wide range of applications
- 5.2.3.1.2. Technology developments
- 5.2.3.1.3. Underused treatment, ineffective GvHD management
- 5.2.4. Mesenchymal stem cells
- 5.2.4.1. Drivers
- 5.2.4.1.1. Huge potential of MSCs
- 5.2.4.1.2. Advantageous cell type for allogenic transplantation
- 5.2.4.2. Restraints & Opportunities
- 5.2.4.2.1. Low number of mesenchymal stem cells in bone marrow
- 5.2.4.3. Potential applications of MSC therapy
- 5.3. Embryonic stem cells
- 5.3.1. Drivers & REStraints
- 5.3.1.1. Immense potential due to pluripotent nature
- 5.3.1.2. Ban on federal funding lifted
- 5.3.1.3. Ethical issues and inadequate safety data
- 5.3.2. Umbilical cord stem cells
- 5.3.3. Neuronal stem cells
- 5.3.4. Dental stem cells
- 5.3.5. Other novel cell types
6. stem cells technology market
- 6.1. Stem cell production
- 6.1.1. Somatic nuclear transfer / Therapeutic cloning
- 6.1.2. IVF (In vitro fertilization)
- 6.1.3. Isolation & Cell culture
- 6.2. Expansion & Sub-culture
- 6.3. Stem cell acquisition
- 6.3.1. Bone marrow harvest
- 6.3.2. Apheresis
- 6.3.3. Umbilical cord blood stem cells acquisition
- 6.4. Cryopreservation & storage
7. Global stem cells services market
- 7.1. Stem cell banking
- 7.1.1. Ethical issues on stem cell banking
- 7.2. Stem cell acquisition & testing
- 7.3. Characterization services
- 7.3.1. HLA typing services
- 7.3.2. Stem cell custom services
- 7.3.3. Stem cell custom antibody services
- 7.4. Molecular biology
- 7.5. Drug screening & target validation
8. Global stem cells applications market
- 8.1. Regenerative medicine
- 8.1.1. Drivers & Restraints
- 8.1.1.1. Simple and cost-effective production method
- 8.1.1.2. Public & political support
- 8.1.1.3. High cost of treatment and low reimbursements
- 8.1.2. Neurological disorders
- 8.1.2.1. Alzheimer' s disease
- 8.1.2.2. Parkinson' s disease
- 8.1.2.3. Multiple sclerosis
- 8.1.2.4. Other diseases
- 8.1.3. Myocardial Infarction & cardiovascular diseases
- 8.1.4. Cancer
- 8.1.4.1. Breast cancer
- 8.1.4.2. Multiple myeloma
- 8.1.4.3. Other cancers
- 8.1.5. Injuries
- 8.1.6. Incontinence
- 8.1.7. Diabetes
- 8.1.8. Orthopedics
- 8.1.9. Liver disorders
- 8.1.10. Hematological disorders
- 8.1.10.1. Other applications
- 8.1.10.1.1. Limb ischemia
- 8.1.10.1.2. Systemic lupus
- 8.2. Drug Discovery & Development
9. Geographic analysis
- 9.1. North America
- 9.2. Europe
- 9.3. Asia
- 9.4. ROW
10. Competitive landscape
11. Company Profiles
- 11.1. Advanced Cell Technology Inc
- 11.2. Aldagen
- 11.3. Angel Biotechnology
- 11.4. Angioblast Systems Inc
- 11.5. Aastrom Biosciences Inc
- 11.6. Athersys
- 11.7. Bioheart Inc
- 11.8. Brainstorm Cell Therapeutics
- 11.9. California Stem Cell
- 11.10. Celgene Corporation
- 11.11. Cellartis AB
- 11.12. Cellerant Therapeutics
- 11.13. Cellular Dynamics International, Inc
- 11.14. Cellular Engineering Technologies
- 11.15. CordLife Ltd
- 11.16. Cytori Therapeutics Inc
- 11.17. ES Cell International
- 11.18. Gamida Cell Ltd
- 11.19. Genzyme Corporation
- 11.20. Geron Corporation Inc
- 11.21. Global Stem Inc
- 11.22. Intercytex
- 11.23. Medistem Inc
- 11.24. Mesoblast Ltd
- 11.25. MultiCell Technologies, Inc
- 11.26. Neostem
- 11.27. Novocell Inc
- 11.28. NeuralStem Biopharmaceuticals, Ltd.
- 11.29. Opexa Therapeutics
- 11.30. Osiris Therapeutics, Inc
- 11.31. Plureon Corp
- 11.32. Pluristem Therapeutics
- 11.33. ReNeuron, Inc
- 11.34. StemCells, Inc
- 11.35. StemLifeLine
- 11.36. t2cure Gmbh
- 11.37. TheraVitae
- 11.38. Thermo Fisher Scientific Inc
- 11.39. Thermogenesis Corporation
- 11.40. VetCell Bioscience Ltd
Appendix
- U.S. Government policies & guidelines FOR STEM CELL RESEARCH
- Patents for united states
- Patents for europe
- Patents for Japan
List of TableS
- SUMMARY TABLE GLOBAL STEM CELL MARKET BY PRODUCT, SERVICES AND TECHNOLOGY
2009-2014 ($ MILLIONS)
- Table 1. Global stem cell market by product 2007-2014 ($ Millions)
- Table 2. Global adult stem cell market by product 2007-2014 ($ Millions)
- Table 3. Global other novel cell types market by product 2007-2014 ($
Millions)
- Table 4. Global stem cell technology market 2007-2014 ($ Millions)
- Table 5. Global stem cell production market by product 2007-2014 ($
Millions)
- Table 6. Global stem cell acquisition market by product 2007-2014 ($
Millions)
- Table 7. Global stem cell services market 2007-2014 ($ Millions)
- Table 8. Global characterization services market 2007-2014 ($ Millions)
- Table 9. GLOBAL STEM CELL APPLICATIONS MARKET BY PRODUCT 2007-2014 ($
MILLIONS)
- Table 10. Global stem cell applications market by geography 2007-2014 ($
Millions)
- Table 11. Global regenerative medicine market by product 2007-2014 ($
Millions)
- Table 12. Global regenerative medicine market by geography 2007-2014 ($
Millions)
- Table 13. Global neurological disorders market by geography 2007-2014 ($
Millions)
- Table 14. Global Myocardial Infarction & cardiovascular diseases market
by geography 2007-2014 ($ Millions)
- Table 15. Global stem cell therapy market for cancer by geography
2007-2014 ($ Millions)
- Table 16. Global stem cell therapy market for Injuries by product
2007-2014 ($ Millions)
- Table 17. Global stem cell therapy market for Injuries by geography
2007-2014 ($ Millions)
- Table 18. Global stem cell therapy market for Incontinence by geography
2007-2014 ($ Millions)
- Table 19. Global stem cell therapy market for Diabetes by geography
2007-2014 ($ Millions)
- Table 20. Global stem cell therapy market for Orthopedics by geography
2007-2014 ($ Millions)
- Table 21. Global stem cell therapy market for Liver disorders by
geography 2007-2014 ($ Millions)
- Table 22. Global stem cell therapy market for Hematological disorders by
geography 2007-2014 ($ Millions)
- Table 23. Global Other regenerative medicines market by geography
2007-2014 ($ Millions)
- Table 24. Global Drug Discovery & Development market by geography
2007-2014 ($ Millions)
- Table 25. New product, technology, service launch IN THE STEM CELLS
MARKET (2008-2009)
- Table 26. agreements and collaborations IN THE STEM CELLS MARKET
(2008-2009)
- Table 27. mergers and acquisition IN THE STEM CELLS MARKET (2008-2009)
List of FIGURES
- Figure 1. STEM CELL MARKET SEGMENTATION
- Figure 2. FACTORS Driving STEM CELL MARKET GROWTH
- Figure 3. FACTORS INHIBITING STEM CELL MARKET GROWTH
- Figure 4. Stem cell application market dynamics
- Figure 5. RELATIVE IMPORTANCE OF FACTORS AFFECTING STEM CELL MARKET
- Figure 6. NIH funding for stem cell research
- Figure 7. patent analysis by geography 2006 to 2008
- Figure 8. Patent analysis by segment 2006 to 2008
- Figure 9. Patent analysis by competitors
- Figure 10. Major market growth factors
- Figure 11. Stem cell classification on the basis of potency
- Figure 12. Stem cell technologies
- Figure 13. Prominent focus areas in regenerative medicine
- Figure 14. Stem cell transplants types
- Figure 15. global Stem cells market by geography ($billion)
- Figure 16. North American Stem cells market
- Figure 17. european Stem cells market
- Figure 18. asian Stem cells market
- Figure 19. row Stem cells market
- Figure 20. Major segments IN THE global stem cell market (2008-2009)
- figure 21. collaborations IN THE global stem cell market (2008-2009)
|
